Vaccines effective against Delta variant of coronavirus: US study


PTI, Sep 14, 2021, 9:57 AM IST

COVID-19 vaccines are effective at preventing hospitalisations and emergency department visits caused by the Delta variant of the SARS-CoV-2 virus, according to a US study.

The research that used national data also indicates that Moderna’s vaccine is significantly more effective against Delta variant than Pfizer and Johnson & Johnson preventives.

“These real-world data show that vaccines remain highly effective at reducing COVID-19 related hospitalisations and emergency department visits, even in the presence of the new COVID-19 variant,” said study author Shaun Grannis, vice president for data and analytics at Regenstrief Institute in the US.

“We strongly recommend vaccinations for all who are eligible to reduce serious illness and ease the burden on our healthcare system, Grannis said in a statement.

The authors noted that the Centers for Disease Control and Prevention (CDC)’s VISION Network has analysed more than 32,000 medical encounters from nine states during June, July and August 2021, when the Delta variant became the predominant strain.

The results showed that unvaccinated individuals with COVID-19 are 5-7 times more likely to need emergency department care or hospitalisation, similar to the overall effectiveness prior to the variant, they said.

The study in Morbidity and Mortality Weekly Report, a weekly epidemiological digest for the US published by CDC, is also the first analysis from the VISION Network to show a marked difference between the effectiveness of the mRNA vaccines.

In the study’s time period, Moderna was 95 per cent effective at preventing hospitalisations among adults aged 18 and older, the authors said.

The Pfizer vaccine was 80 per cent effective while the Johnson & Johnson preventive was 60 per cent effective at preventing hospitalisations among adults ages 18 and older, they said.

The study also found that vaccine effectiveness is lower for people 75 years and older, which has not been shown in previous research.

The researchers explained that this could be due to a range of factors, including the increased time since vaccination.

When it came to preventing emergency department and urgent care visits, analysis showed that Moderna was 92 per cent effective, Pfizer was 77 per cent effective, while Johnson & Johnson was 65 per cent effective.

“Despite the differences in effectiveness, vaccines continue to offer much more protection than not getting one at all,” said Grannis, who is also a professor at Indiana University School of Medicine, US.

“While breakthrough cases do happen, data shows the symptoms are less severe, he said.

The authors of the study noted that a vast majority of COVID hospitalisations and deaths continue to be among unvaccinated individuals.

They added that COVID-19 vaccines are powerful tools for combating the pandemic.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Rift in Karnataka BJP: Renukacharya faction wants party to expel Yatnal

Tough decisions have to be taken, need to learn from poll results: Kharge at CWC meet

MSRTC bus overturns in Gondia district; 9 passengers killed, 25 injured

BJP slams move to make Karnataka CM as RDPR varsity chancellor replacing Guv

Heavy rains expected in north, central Kerala in next few days

Karnataka cabinet expansion unlikely: Shivakumar

Siddaramaiah meets PM Modi, seeks urgent clearances for two irrigation projects

Related Articles More

Doctor-population ratio in country is better than WHO standard: Nadda

Genetic vulnerability for low insulin, unhealthy fat major causes for diabetes in South Asians: Study

Study links overthinking to ‘constant communication’ between brain’s fear-centre, social behaviour

Mangaluru: Campco opposes WHO’s claim of arecanut being carcinogenic

10 month baby gets new heart, new life

MUST WATCH

Grafting

Coconut Flower

Prakash Belawadi

Naxal Leader Vikram Gowda

Christmas Cake Fruit Mixing


Latest Additions

Rift in Karnataka BJP: Renukacharya faction wants party to expel Yatnal

Champions Trophy: PCB sticks to ‘No Hybrid Model’ stance, meeting adjourned till Saturday

Tough decisions have to be taken, need to learn from poll results: Kharge at CWC meet

Sensex rebounds 759 pts, Nifty ends above 24,100 on gains in Airtel, RIL

SIT begins probe into Tirupati laddu adulteration allegations

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.